MUFG Securities Americas’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$783K Buy
11,622
+973
+9% +$64.8K 0.04% 339
2026
Q1
$669K Buy
10,649
+142
+1% +$9.89K 0.04% 338
2025
Q4
$697K Sell
10,507
-68
-0.6% -$4.4K 0.04% 327
2025
Q3
$712K Buy
10,575
+1,885
+22% +$149K 0.05% 317
2025
Q2
$759K Buy
8,690
+1,774
+26% +$139K 0.06% 260
2025
Q1
$472K Buy
6,916
+1,149
+20% +$93.8K 0.05% 299
2024
Q4
$449K Buy
+5,767
New +$427K 0.06% 293

Other funds holding DXCM

MUFG Securities Americas's DXCM Position: Q2 2026 in Review

MUFG Securities Americas increased its DexCom (DXCM) stake by 9.1% in Q2 2026, buying an estimated $64.8K and bringing the position to 11,622 shares worth $783K. The position accounts for 0.04% of the portfolio, ranked #339.

MUFG Securities Americas first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • MUFG Securities Americas held 11,622 shares of DexCom worth $783K as of Q2 2026.
  • MUFG Securities Americas bought 973 DexCom shares in Q2 2026, an estimated $64.8K.
  • DexCom made up 0.04% of MUFG Securities Americas's portfolio in Q2 2026, its #339 holding.
  • MUFG Securities Americas first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.